Balser JR, 1998 [58]
|
Randomized controlled
|
APACHE III
|
59
|
Within 2 h
|
Esmolol
|
59.1% [20/34]
|
p = 0.067
|
31
|
65
|
Diltiazem
|
27.3% [6/22]
|
38
|
Seguin P, 2006 [51]
|
Prospective observational
|
SAPS II
|
47
|
10 ± 10 h
|
DC
|
100% [3/3]
|
NA
|
31.2
|
Amiodarone
|
100% [4/4]
|
Digoxin
|
100% [1/1]
|
No intervention
|
100% [4/4]
|
Sleeswijk ME, 2008 [59]
|
Prospective observational
|
APACHE II
|
19
|
Within 24 h
|
MgSO4-amiodarone step-up scheme
|
93.1% [27/29]
|
NA
|
37.9
|
Meierhenrich R, 2010 [53]
|
Prospective observational
|
SAPS II
|
31a
|
NA
|
DC (17/49)
|
85.7% [42/49]c
|
NA
|
48ad
|
34b
|
Amiodarone (36/49)
|
23bd
|
Digitalis (31/49)
|
β-Blockers (25/49)
|
Kanji S, 2012 [55]
|
Retrospective observational
|
APACHE II
|
22.6
|
Within 24 h
|
DCe
|
26.9% [7/26]
|
NA
|
32
|
Amiodaronef
|
87.4% [90/103]
|
Sotalol
|
100% [2/2]
|
Rate control
|
75% [21/28]
|